Global Pharmaceutical Leader Secures Sensitive Data and Ensures Compliance Across SaaS Estate

The Challenge

The company needed to secure its rapidly growing SaaS portfolio, which contained highly sensitive data critical to medical breakthroughs. It faced:

• An overwhelming number of new SaaS security controls and configurations
• Limited resources to manually monitor, assess, and update cloud security posture
• Uncertainty and skepticism around vendor-provided security assurances
• Difficulty achieving true Zero Trust without full insight into user access, security drift, and SaaS risks

Manual processes were unsustainable, putting regulatory compliance and critical data at risk.

Read how this pharma leader gained real-time SaaS visibility and compliance confidence with AppOmni.

“AppOmni definitely stuck out from basically hour one… The immersion into our needs, and what it is we want to do, and which SaaS solutions we wanted to cover, were great from day one. And it’s been a complete success.”

— Security Leader at a Global Pharmaceuticals Company

The Requirements 

The company needed a SaaS security partner that could support:

The Results

With AppOmni, the pharma company:

• Achieved comprehensive SaaS estate visibility and access control
• Simplified compliance with automated monitoring and reporting
• Enabled fast, confident onboarding of new SaaS systems
• Reduced reliance on vendor security claims through independent risk assessment
• Advanced a Zero Trust model across all SaaS platforms

Why It Matters

AppOmni enables the company’s security team to protect sensitive research data, maintain regulatory compliance, and scale SaaS adoption securely—empowering the organization to focus on innovation and patient outcomes.